Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Tanabe synthesizes ET antagonists

Feb. 5, 1997

PDE IV/TNF production inhibitors claimed by Pfizer

Feb. 5, 1997

Merck & Co. pursues alpha1a-adrenoceptor antagonists for BPH

Feb. 5, 1997

Pineal gland-specific gene-1 disclosed by HGS

Feb. 5, 1997

Takeda discloses novel cephems

Feb. 5, 1997

Analogues of botulinum toxin discovered with longer half-life

Feb. 5, 1997

Bone morphogenic protein-10 claimed by Human Genome Sciences

Feb. 5, 1997

HMR describes new cognition-enhancing agents

Feb. 5, 1997

NES-1 polypeptides reported for carcinoma detection and treatment

Feb. 5, 1997

MRI image-enhancing agents claimed by Nycomed Imaging

Feb. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...